NIDA

NEW YORK (GenomeWeb) – The University of Chicago said on Thursday it has been awarded a five-year, $12 million grant from the National Institute on Drug Abuse to create a center of excellence using rats to study the genetics of drug abuse.

NEW YORK (GenomeWeb) – RUCDR Infinite Biologics, a unit of the Rutgers Human Genetics Institute of New Jersey, has received a $19 million contract from the National Institute on Drug Abuse to expand the service offerings it provides through the NIDA Center for Genetic Studies, the Rutgers Office

NEW YORK (GenomeWeb News) – The National Institute on Drug Abuse plans to commit $2 million in Fiscal Year 2015 to spur small businesses to development of new tools for monitoring and manipulating covalently modified eukaryotic mRNAs and regulatory RNAs, NIDA

NEW YORK (GenomeWeb News) – The National Institute on Drug Abuse plans to fund research and development projects investigating the genomic characteristics and molecular pathways that may play roles in addiction.

NEW YORK (GenomeWeb News) –The National Institute on Drug Abuse plans to fund research efforts to develop new methods for sequencing, mapping, and analyzing genomes of animals that have been bred to have traits related to addiction, with the aim of identifying gene variants that may be involved i

NEW YORK (GenomeWeb News) – The National Institutes of Health plans to award $11.3 million to fund a number of research projects that will develop computational approaches for interpreting sequence variants found in the non-protein-coding regions of the human genome.

NEW YORK (GenomeWeb News) – The National Institutes of Health is planning to fund research into the genetic and epigenetic factors that may promote alcohol and drug co-addiction, according to a funding announcement published this week.

NEW YORK (GenomeWeb News) – The National Institute on Drug Abuse plans to fund new research projects that aim to discover more about the changes that chronic exposure to drugs cause in the brain, including efforts focused on changes at the genetic, molecular, and cellular levels.